Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.7%

1 terminated/withdrawn out of 15 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 1

8(53.3%)

Phase 2

4(26.7%)

Phase 3

3(20.0%)

15Total

Phase 1(8)

Phase 2(4)

Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07122453Phase 1Recruiting

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

Role: lead

NCT04857957Phase 1Completed

Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Role: lead

NCT03429049Phase 3Completed

A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain

Role: lead

NCT03660943Phase 3Completed

A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain

Role: lead

NCT03661996Phase 3Completed

An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA

Role: lead

NCT04154501Phase 1Completed

A Study to Evaluate the Safety and Pharmacokinetics of CNTX-6016 in Healthy Subjects

Role: lead

NCT03787004Phase 1Completed

A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects

Role: lead

NCT03472677Phase 1Completed

The Effect of Injection Site Cooling on Pain Experienced After the Administration of CNTX-4975-05 Into the Knee

Role: lead

NCT03576508Phase 1Completed

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

Role: lead

NCT02678793Phase 2Completed

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Role: lead

NCT02558439Phase 2Completed

Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

Role: lead

NCT00667654Phase 2Completed

Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)

Role: lead

NCT02283957Phase 2Completed

A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Role: lead

NCT02679339Phase 1Terminated

Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain

Role: lead

NCT02550756Phase 1Completed

Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Role: lead

All 15 trials loaded